JP2009503094A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009503094A5 JP2009503094A5 JP2008525134A JP2008525134A JP2009503094A5 JP 2009503094 A5 JP2009503094 A5 JP 2009503094A5 JP 2008525134 A JP2008525134 A JP 2008525134A JP 2008525134 A JP2008525134 A JP 2008525134A JP 2009503094 A5 JP2009503094 A5 JP 2009503094A5
- Authority
- JP
- Japan
- Prior art keywords
- mmhg
- blood pressure
- substituted
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C1=C(*)S=C(*)*1 Chemical compound *C1=C(*)S=C(*)*1 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70563505P | 2005-08-03 | 2005-08-03 | |
| US60/705,635 | 2005-08-03 | ||
| PCT/US2006/030023 WO2007019153A2 (en) | 2005-08-03 | 2006-08-02 | Methods for treating hypertension |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009503094A JP2009503094A (ja) | 2009-01-29 |
| JP2009503094A5 true JP2009503094A5 (cg-RX-API-DMAC10.html) | 2009-07-02 |
| JP5242393B2 JP5242393B2 (ja) | 2013-07-24 |
Family
ID=37727864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525134A Expired - Fee Related JP5242393B2 (ja) | 2005-08-03 | 2006-08-02 | 高血圧症の治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20070167454A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1940397A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5242393B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2617248C (cg-RX-API-DMAC10.html) |
| WO (1) | WO2007019153A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006121995A2 (en) * | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| CA2669935A1 (en) * | 2006-11-13 | 2008-05-29 | Takeda Pharmaceuticals North America, Inc. | Methods for preserving renal function using xanthine oxidoreductase inhibitors |
| US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
| RU2009131454A (ru) * | 2007-01-19 | 2011-02-27 | Такеда Фармасьютикалз Норт Америка, Инк. (Us) | Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств |
| WO2008126772A1 (ja) * | 2007-04-05 | 2008-10-23 | Astellas Pharma Inc. | 高血圧治療剤 |
| US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
| US9545445B2 (en) | 2009-06-26 | 2017-01-17 | Teijin Pharma Limited | Therapeutic drug for hypertension or prehypertension |
| IT1400309B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso. |
| IT1400311B1 (it) * | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. |
| IT1400609B1 (it) | 2010-05-10 | 2013-06-14 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e metformina e loro uso. |
| IT1400310B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e statine e loro uso. |
| AR082022A1 (es) * | 2010-06-25 | 2012-11-07 | Teijin Pharma Ltd | Agente terapeutico de liberacion sostenida para la hipertension y la disfuncion renal |
| JP5978216B2 (ja) | 2010-09-10 | 2016-08-24 | タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド | テオフィリンとフェブキソスタットの併用療法のための方法 |
| WO2013111870A1 (ja) | 2012-01-27 | 2013-08-01 | 帝人ファーマ株式会社 | 糖尿病の治療薬 |
| JP6732004B2 (ja) | 2016-02-19 | 2020-07-29 | 国立大学法人鳥取大学 | 認知症治療薬または予防薬 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4058614A (en) * | 1973-12-04 | 1977-11-15 | Merck & Co., Inc. | Substituted imidazole compounds and therapeutic compositions therewith |
| US4296122A (en) * | 1975-07-09 | 1981-10-20 | Merck & Co., Inc. | 2,3-Dihydro-6,7-disubstituted-5-(acyl)benzofuran-2-carboxylic acids |
| DE2727802A1 (de) * | 1977-06-21 | 1979-04-19 | Hoechst Ag | Sulfamoyl-arylketone und verfahren zu ihrer herstellung |
| US4510322A (en) * | 1981-07-13 | 1985-04-09 | Merck & Co., Inc. | Indacrinone having enhanced uricosuric |
| US4632930A (en) * | 1984-11-30 | 1986-12-30 | E. I. Du Pont De Nemours And Company | Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives |
| JPH0366669A (ja) * | 1989-08-03 | 1991-03-22 | Shionogi & Co Ltd | 複素環式化合物 |
| CA2073981C (en) * | 1990-11-30 | 2002-01-08 | Shiro Kondo | 2-arylthiazole derivatives and pharmaceutical composition thereof |
| US5358961A (en) * | 1991-11-30 | 1994-10-25 | Jin Ro Limited | Pyrrolidine derivatives |
| SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| GB9824310D0 (en) * | 1998-11-05 | 1998-12-30 | Univ London | Activators of soluble guanylate cyclase |
| US6281222B1 (en) * | 1999-08-19 | 2001-08-28 | Inotek Corporation | Compositions and method for treatment of acetaminophen intoxication |
| EP1317258B1 (en) * | 2000-06-28 | 2009-02-11 | Merck & Co., Inc. | Use of allopurinol for the treatment of hypertension |
| CA2463441A1 (en) * | 2001-10-12 | 2003-05-08 | Bayer Pharmaceuticals Corporation | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity |
| DK1471065T3 (da) * | 2002-01-28 | 2008-03-25 | Fuji Yakuhin Co Ltd | Hidtil ukendt 1,2,4-triazolforbindelse |
| US20060040945A1 (en) * | 2002-05-17 | 2006-02-23 | Merckle Gmbh | Annellated pyrrole compounds as proton pump inhibitors for treating ulcer |
| US20040131676A1 (en) * | 2002-12-20 | 2004-07-08 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
| US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
| WO2005018635A2 (en) * | 2003-08-07 | 2005-03-03 | Cardiome Pharma Corp. | Ion channel modulating activity i |
| WO2006121995A2 (en) * | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| CA2669935A1 (en) * | 2006-11-13 | 2008-05-29 | Takeda Pharmaceuticals North America, Inc. | Methods for preserving renal function using xanthine oxidoreductase inhibitors |
| US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
| RU2009131454A (ru) * | 2007-01-19 | 2011-02-27 | Такеда Фармасьютикалз Норт Америка, Инк. (Us) | Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств |
| US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
| JP5978216B2 (ja) * | 2010-09-10 | 2016-08-24 | タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド | テオフィリンとフェブキソスタットの併用療法のための方法 |
-
2006
- 2006-08-02 WO PCT/US2006/030023 patent/WO2007019153A2/en not_active Ceased
- 2006-08-02 US US11/497,608 patent/US20070167454A1/en not_active Abandoned
- 2006-08-02 EP EP06774718A patent/EP1940397A4/en not_active Withdrawn
- 2006-08-02 CA CA2617248A patent/CA2617248C/en not_active Expired - Fee Related
- 2006-08-02 JP JP2008525134A patent/JP5242393B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-07 US US14/246,551 patent/US20140329868A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010509372A5 (cg-RX-API-DMAC10.html) | ||
| RU2436780C2 (ru) | Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы | |
| RU2439068C2 (ru) | Модуляторы mglur5 | |
| RU2009122505A (ru) | Способы сохранения функции почек с использованием ингибиторов ксантин оксидоредуктазы | |
| JP2011507868A5 (cg-RX-API-DMAC10.html) | ||
| JP2004517087A5 (cg-RX-API-DMAC10.html) | ||
| JP2013539747A5 (cg-RX-API-DMAC10.html) | ||
| JP2017523972A5 (cg-RX-API-DMAC10.html) | ||
| JP2008513515A5 (cg-RX-API-DMAC10.html) | ||
| JP2007523182A5 (cg-RX-API-DMAC10.html) | ||
| CA2710409A1 (en) | 6h-dibenz0 [b,e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists | |
| JP2010515715A5 (cg-RX-API-DMAC10.html) | ||
| JP2004517080A5 (cg-RX-API-DMAC10.html) | ||
| JP2010513319A5 (cg-RX-API-DMAC10.html) | ||
| JP2014532070A5 (cg-RX-API-DMAC10.html) | ||
| WO2012048181A4 (en) | Novel substituted quinoline compounds as s-nitrosoglutathione reductase inhibitors | |
| JP2002534519A5 (cg-RX-API-DMAC10.html) | ||
| RU2013138569A (ru) | Антагонисты рецептора минералокортикоидов | |
| JP2004520292A5 (cg-RX-API-DMAC10.html) | ||
| RU2013109380A (ru) | Способ сопутствующей терапии с применением теофиллина и фебуксостата | |
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2019537603A5 (cg-RX-API-DMAC10.html) | ||
| JP2010505809A5 (cg-RX-API-DMAC10.html) | ||
| JP2015524483A5 (cg-RX-API-DMAC10.html) | ||
| US20100311756A1 (en) | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |